CYTL1: A Drug Target / Disease Biomarker (G54360)

Target Name: CYTL1

NCBI ID: G54360

CYTL1

CYTL1: A Drug Target / Disease Biomarker

CYTL1, also known as interleukin-8 (IL-8), is a protein that is expressed in a variety of tissues throughout the body. It is a cytokine, which means it is a protein that is derived from the cytoplasm of a cell and functions as a signaling molecule. CYTL1 is involved in the regulation of a wide range of physiological processes, including inflammation, immune response, and cell growth.

One of the things that makes CYTL1 an attractive drug target is its ability to interact with a variety of different signaling pathways. CYTL1 has been shown to interact with a number of different signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These signaling pathways are involved in a wide range of biological processes, including cell growth, differentiation, and inflammation.

CYTL1 has also been shown to play a role in the regulation of pain. Studies have shown that CYTL1 is involved in the regulation of pain sensitivity and that it plays a role in the development of chronic pain.

In addition to its role in pain regulation, CYTL1 has also been shown to be involved in the regulation of a number of other physiological processes. For example, it has been shown to play a role in the regulation of inflammation, immune response, and cell death.

Given its involvement in a wide range of physiological processes, CYTL1 is an attractive drug target for a variety of different diseases. For example, CYTL1 has been shown to be involved in the development of cancer, and it has been shown to play a role in the regulation of cancer cell growth and metastasis.

In addition to its potential as a drug target, CYTL1 is also a potential biomarker. The ability of CYTL1 to interact with a variety of different signaling pathways makes it a potential marker for a wide range of different diseases. For example, CYTL1 has been shown to be involved in the regulation of cancer, and it has been shown to be expressed in a variety of different types of cancer.

Overall, CYTL1 is a protein that is expressed in a variety of tissues throughout the body and is involved in a wide range of physiological processes. Its ability to interact with a variety of different signaling pathways makes it an attractive drug target and a potential biomarker for a variety of different diseases. Further research is needed to fully understand the role of CYTL1 in biology and to develop effective treatments for the diseases that are associated with its dysfunction.

Protein Name: Cytokine Like 1

The "CYTL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYTL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets